e-learning
resources
Amsterdam 2015
Tuesday, 29.09.2015
Monitoring and phenotyping COPD
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The potential value of FRAX index and bone turnover markers to identify osteoporosis in COPD patients
Pilar Rivera Ortega (Barcelona, Spain), Pilar Rivera-Ortega, Jessica González-Gutiérrez, Patricia Restituto, Nerea Varo, Amparo Calleja, Macarena Rodríguez, Ana B. Alcaide, Arantza Campo, Javier J. Zulueta, Juan P. De Torres
Source:
International Congress 2015 – Monitoring and phenotyping COPD
Session:
Monitoring and phenotyping COPD
Session type:
Poster Discussion
Number:
3350
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Pilar Rivera Ortega (Barcelona, Spain), Pilar Rivera-Ortega, Jessica González-Gutiérrez, Patricia Restituto, Nerea Varo, Amparo Calleja, Macarena Rodríguez, Ana B. Alcaide, Arantza Campo, Javier J. Zulueta, Juan P. De Torres. The potential value of FRAX index and bone turnover markers to identify osteoporosis in COPD patients. Eur Respir J 2015; 46: Suppl. 59, 3350
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Is COPD an independent predictor of osteoporosis?
Source: International Congress 2015 – COPD: notable points
Year: 2015
Relationship between annual change of bone mineral density, emphysema and pulmonary function in patients with COPD
Source: International Congress 2015 – COPD: notable points
Year: 2015
The decrease of nutritional status and increasing of the risk of osteoporotic fractures in patients with chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2013 –COPD biomarkers
Year: 2013
Bone stiffness and failure load are related with clinical features of COPD
Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities
Year: 2013
Biological and phenomenological markers of ageing in patients with COPD and their relationship to CT emphysema scores
Source: International Congress 2015 – Notable abstracts in COPD: variety
Year: 2015
COPD related fatigue (COPD-RF) as a patient centred outcome tool in COPD: Various predictors and its correlation with other outcome parameters
Source: International Congress 2016 – Monitoring airway diseases with clinical tools
Year: 2016
What is the best biomarker of COPD stability?
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
The role of COPD in development of osteoporosis
Source: International Congress 2014 – Markers
Year: 2014
Associations between arterial calcification and stiffness, bone density, emphysema and all-cause mortality in COPD patients
Source: Annual Congress 2013 –The best posters in chronic care
Year: 2013
Hypogonadism as a factor influencing health condition in COPD patients
Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities
Year: 2016
Comparing non-invasive cardiovascular risk assessment tools in COPD patients: Validation with CV events
Source: International Congress 2014 – Respiratory disease within hospital-based populations
Year: 2014
COPDCoRi, an algorithm for predicting the risk of coronaropathy in COPD patients
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014
COPD and BMI at primary level
Source: International Congress 2015 – Different data in COPD
Year: 2015
A multimarker approach to identify atherosclerosis in COPD
Source: International Congress 2014 – Markers
Year: 2014
Microalbuminuria as a cardiovascular biomarker in patients with COPD
Source: International Congress 2016 – Systemic biomarkers
Year: 2016
FRAX program as a method of assessing the risk of osteoporotic fractures in patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD is not a pulmonary disease alone
Year: 2012
COPD screening and risk factor frequency identification study
Source: Annual Congress 2013 –Disease control and quality of life in airway diseases
Year: 2013
Impact of comorbidities in COPD prognosys scores
Source: International Congress 2016 – Features and impact of comorbidities in COPD
Year: 2016
The absolute risk of osteoporotic fractures according to the program of FRAX patients with chronic obstructive pulmonary disease
Source: Annual Congress 2012 - COPD is not a pulmonary disease alone
Year: 2012
Current status of research on osteoporosis in COPD: a systematic review
Source: Eur Respir J 2009; 34: 209-218
Year: 2009
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept